White River Junction, VT, United States of America

Anthony B Cooper

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 5.3

ph-index = 4

Forward Citations = 25(Granted Patents)


Location History:

  • White River Junction, VT (US) (2019 - 2022)
  • Lebanon, NH (US) (2021 - 2022)

Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Unveiling the Innovations of Inventor Anthony B Cooper

Introduction:

Anthony B Cooper, a prolific inventor hailing from White River Junction, VT (US), has made significant contributions to the field of biotechnology. With an impressive portfolio of 7 patents under his belt, Cooper's latest developments in the realm of antibodies showcase his unwavering dedication to advancing medical science.

Latest Patents:

Cooper's recent patents display his groundbreaking work in the development of antibodies with potent therapeutic potential. The "Anti-TIGIT antibodies" and "Anti-Sortilin antibodies" patents highlight his ability to create innovative solutions that effectively target specific biological pathways, paving the way for novel treatment strategies.

Career Highlights:

Having worked with esteemed companies such as Alector LLC and Iteos Therapeutics SA, Cooper has honed his skills and expertise in the biotech industry. His tenure at these organizations has been marked by a relentless pursuit of innovation, culminating in the successful fruition of cutting-edge technologies that hold immense promise for the future of healthcare.

Collaborations:

Collaboration lies at the heart of Cooper's success, with notable colleagues like Arnon Rosenthal and Tina Schwabe contributing to the realization of his visionary ideas. Together, they have formed a formidable team that thrives on creativity, teamwork, and a shared passion for driving scientific progress.

Conclusion:

Inventor Anthony B Cooper stands as a shining example of ingenuity and perseverance in the field of biotechnology. His trailblazing inventions underscore his commitment to pushing the boundaries of scientific discovery and transforming the landscape of modern medicine. As he continues to redefine what is possible in the realm of antibody-based therapeutics, the world eagerly anticipates the next chapter in Cooper's remarkable journey of innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…